Details
Stereochemistry | RACEMIC |
Molecular Formula | C5H8O5 |
Molecular Weight | 148.114 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(CCC(O)=O)C(O)=O
InChI
InChIKey=HWXBTNAVRSUOJR-UHFFFAOYSA-N
InChI=1S/C5H8O5/c6-3(5(9)10)1-2-4(7)8/h3,6H,1-2H2,(H,7,8)(H,9,10)
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: O75164 Gene ID: 9682.0 Gene Symbol: KDM4A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21460794 |
79.0 µM [IC50] | ||
Target ID: CHEMBL1938210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21460794 |
48.0 µM [IC50] | ||
Target ID: Q6NS38 Gene ID: 121642.0 Gene Symbol: ALKBH2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21460794 |
150.0 µM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. | 2011 May |
|
Untangling the Metabolic Reprogramming in Brain Cancer: Discovering Key Molecular Players Using Mass Spectrometry. | 2019 |
|
Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry. | 2019 Aug 2 |
|
Discovery of new small molecule inhibitors targeting isocitrate dehydrogenase 1 (IDH1) with blood-brain barrier penetration. | 2019 Dec 1 |
|
I-8, a novel inhibitor of mutant IDH1, inhibits cancer progression in vitro and in vivo. | 2019 Dec 1 |
|
Friend or foe-IDH1 mutations in glioma 10 years on. | 2019 Nov 25 |
|
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. | 2019 Oct |
|
Magnetic Resonance Spectroscopic Assessment of Isocitrate Dehydrogenase Status in Gliomas: The New Frontiers of Spectrobiopsy in Neurodiagnostics. | 2020 Jan |
|
Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells. | 2020 Mar |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
alpha-Hydroxyglutaric acid
Created by
admin on Sat Dec 16 18:06:03 GMT 2023 , Edited by admin on Sat Dec 16 18:06:03 GMT 2023
|
PRIMARY | |||
|
DTXSID40864360
Created by
admin on Sat Dec 16 18:06:03 GMT 2023 , Edited by admin on Sat Dec 16 18:06:03 GMT 2023
|
PRIMARY | |||
|
RS4M3UYS95
Created by
admin on Sat Dec 16 18:06:03 GMT 2023 , Edited by admin on Sat Dec 16 18:06:03 GMT 2023
|
PRIMARY | |||
|
17084
Created by
admin on Sat Dec 16 18:06:03 GMT 2023 , Edited by admin on Sat Dec 16 18:06:03 GMT 2023
|
PRIMARY | |||
|
43
Created by
admin on Sat Dec 16 18:06:03 GMT 2023 , Edited by admin on Sat Dec 16 18:06:03 GMT 2023
|
PRIMARY | |||
|
2889-31-8
Created by
admin on Sat Dec 16 18:06:03 GMT 2023 , Edited by admin on Sat Dec 16 18:06:03 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD